Incyte reviews

Weak management with little experience, yet they are given critical decision making responsibilities resulting in motivated employees leaving. Decision making is erratic and unorganized. This company promotes clear favoritism and unfair sex discrimination. Their stock continues on a decline and I think we know why.

Look no further than the performance of Incyte's stock. This will tell you it's a good company but not a great one. As an S&P 500 member it's appalling how poorly it's performed. Take a look at the past 10 years and you will see the S&P had risen 180% while Incyte stock has only risen 24% over that time. Or how about the past 5 years where the S&P is up 91% vs Incyte being DOWN 25%. The past 2 years; S&P up 29% vs Incyte DOWN 16%. Or finally just the past 12 months; S&P up 27% while DOWN 3% here. Terrible no matter what timeline you look at. Or we can zoom in and look at just the Healthcare sector. But it's the same story. S&P up 82% in 10 yrs, 65% in 5, 13% in 2 and 15% in past 12 months vs. the above Incyte performance. Completely suboptimal execution. Leadership continues to say they are doing a great job even though the stock says the opposite. This organization needs a change agent at the top and maybe across the entire board. They can no longer just sit there and accept the status quo. It's unacceptable and shareholders deserve better. Until then, this will only be a good company but never a great one.